Apexigen

Specialty company that develops anti-body therapeutics for the treatment of cancer

placeSan Carlos, California, United States calendar_todayFounded 2010 groups28 employees language apexigen.com

Registered entities

Innovation

15 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,992 times.

YearFilings
20147
20158
20166
20175
20188
20195
20206
20217
20224
20235
20244
20252

Investor mix

20 investors on record; lead investors include Amkey Ventures, Decheng Capital, 3E Bioventures Capital, VI Ventures.

Investor typeCountShare
Venture capital1365%
Private equity420%
Other / undisclosed315%
Coming soon